Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors

Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors

Triple-negative breast cancer refers to breast cancer patients with negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2). Metastatic triple-negative breast cancer is predominantly treated with chemotherapy, but later-line treatment remains cha...

Full description

Bibliographic Details
Main Authors: Ruoyan Qin, Jie Qian, Mengjun Shan, Guangxin Ruan, Xiaofeng Yang, Yanwen Wang, Lingshuang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
triple-negative breast cancer
metastases
altered hormone receptors
later-line treatment
endocrine therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1023787/full

Similar Items

Similar Items